The Rel/NF-κB family of transcription factors: A complex system for regulatory cell control;Les facteurs de transcription Rel/NF-κB: Rôle complexe dans les régulations cellulaires

Pathologie Biologie

Volumn 50, Issue 3, 2002, Pages 204-211

  Bottex Gauthier, C ^a   Pollet, S ^a,b   Favier, A ^b   Vidal, D R ^a  

^a CENTRE DE RECHERCHES   (France)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Diseases; I B; NF B; Regulation; Transcription

Indexed keywords

DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CANCER; CELLULAR DISTRIBUTION; CYTOLOGY; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; INFECTION; INFLAMMATION; NUCLEAR LOCALIZATION SIGNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; STRESS;

EID: 0036228277     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00289-4     Document Type: Review

References (80)

1. The NF-κB and the IκB proteins: New discoveries and insights
2. NF-κB and rel proteins in innate immunity
3. Regulation of NF-κB and disease control: Identification of a novel seine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation
4. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism
5. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit
6. Regulation of the NF-kappa B inhibitor system
7. Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway
8. The ubiquitin-proteasome pathway is required for processing the NF-κB 1 precursor protein and the activation of NF-κB
9. Function and activation of NF-κB in the immune system
10. Multiple redox regulation in NF-κB transcription factor activation
11. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
12. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors
13. The I kappa B proteins: Members of a multifunctional family
14. The crystal structure of the I kappa B alpha/NF-kappa B inactivation
15. Rel-associated p40: An inhibitor of the Rel family of transcription factors
16. Characterization of an immediate-early gene induced in adherent monocytes that encode IκB-like activity
17. Constitutive phosphorylation of I kappa B alpha by casein kinase II
18. Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases
19. Tyrosine phosphorylation of I kappa-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
20. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation
21. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: Role of ankyrin repeats in the inhibition of DNA binding activity
22. IκB-β regulates the persistent response in a biphasic activation of NF-κB
23. I kappa B epsilon, a novel member of the I kappa B family, controls Rel A, and c rel NF-kappa B activity
24. A functional role of I kappa B epsilon in endothelial cell activation
25. The candidate proto-oncogene Bcl-3 is related to genes implicated in cell lineage determination and cell cycle control
26. Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimer in vivo
27. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers
28. Bcl-3-mediated nuclear regulation of the NF-kappa B trans-activating factor
29. Bcl-3 encodes a nuclear protein which can alter the subcellular location of NF-κB proteins
30. The candidate onco-protein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition
31. Cloning of the p50 Dna binding subunit of Nf-κB: homology to rel and dorsal
32. The NF-κB p50 precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50
33. IκB-γ a 70-kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family
34. Rel/NF kappa B/I kappa B story
35. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors
36. Cytokine-inducible expression in endothelial cells of IκB-α-like gene is regulated by NF-κB
37. Site-specific phosphorylation of IκB-α by a novel ubiquitination-dependent protein kinase activity
38. Control of IκBα proteolysis by site-specific, signal induced phosphorylation
39. Lipopolysaccharide induces phosphorylation of MAD3 and activation of C-rel and related NF-κB proteins in human monocytic THP-1 cells
40. Mapping of the inducible IκB phosphorylation sites signal its ubiquifination and degradation
41. NF-κB activation: The IκB kinase revealed?
42. Promoter analysis of yhe gene encoding the Iκb-α/MAD 3 inhibitor of Nf-κB: Positive regulation by members of the rel/NF-κB family
43. Autoregulation of I kappa B alpha activity
44. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α
45. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: A mechanism for cytoplasmic retention
46. The C terminus of the NF-κB p50 precursor and an IκB isoform contain transcription activation domains
47. Embryonic lethality and liver degeneration in mice lacking the Rel A component of NF-κB
48. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
49. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of Rel B, a member of the NF-κB/Rel family
50. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
51. IκB-α overexpression delays tumor formation in v-Rel transgenic mice
52. Both multiorgan inflammation and myeloid hyperplasia in Rel B-deficient mice are T cell dependent
53. IκB-α deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice
54. NF-κB and rel-participants in a multiform transcriptional regulatory system
55. NF-κB: An oxidative stress-responsive transcription factor of eukaryotic cells
56. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells
57. Inflammation, free radicals and antioxidants
58. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules
59. Ionizing radiation induces expression and binding activity of the nuclear factor κB
60. NF-kappa B: An important transcription factor in photobiology
61. The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage
62. Dengue virus replication in human hepatoma cells activates NF-κB which in turn induces apoptotic cell death
63. Activates NF-κB or die?
64. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes
65. Bcl2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis
66. Neuroprotection of aspirin and sodium salicylate through blockade of NF-κB activation
67. TNF and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
68. Suppression of TNF-α induced apoptosis by NF-κB
69. NF-κB and chemoresistance: Could NF-κB be an antitumor target?
70. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
71. NF-κB antiapoptosis: Induction of TRAF1 and TRAF-2 and c-IAPI and c-IAP2 to suppress caspase 8 activation
72. The prosurvival Bcl-2 homolog Bfl-I/AI is a direct transcriptional target of NF-kappa B that blocks TNF alpha-induced apoptosis
73. Transcription factor NF-κB is activated in primary neurons by amyloid βA4 and in neurons surrounding early plaques from Alzheimer disease patients
74. The NF-κB and the IκB proteins: New discoveries and insights
75. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression
76. Role of transcriptional activation of IκB-α in mediation of immunosuppression by glucocorticoids
77. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
78. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids
79. Salicylates inhibit IκB-α phosphorylation, endothelial-leucocyte adhesion molecule expression, and neutrophil transmigration
80. Oxidation of salicylate by stimulated granulocytes: Evidence that these drugs act as free radical scavengers in biological systems